Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Anil-
dc.contributor.authorSingh, Arti-
dc.contributor.authorAggarwal, Archi-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.description.abstractAlzheimer’s disease (AD) is a well known progressive neurodegenerative disorder having complex pathophysiology. Currently, drugs that are used symptomatically in the treatment of AD include acetylcholinesterase inhibitors (AChEIs) (rivastigmine, galantamine, donepezil) and N-methyl D-aspartate (NMDA) receptor antagonist (memantine). Limited bioavailability of these drugs stresses continuity of search for novel therapeutics for this slow growing but complex disease. Herbal drugs are being used to treat memory related problems, including Alzheimer’s from time immemorial. Both preclinical and clinical studies demonstrated the therapeutic potential of herbal drugs for the prevention of AD. Herbal drugs have been shown to be effective against Alzheimer’s possibly due to their pleiotropic and multifaceted action that includes antioxidants, anti-inflammatory and neuroprotective action. This review highlights the therapeutic potential of herbal drugs for the treatment of AD.en_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.55(02) [February 2017]en_US
dc.subjectAcetylcholinesterase inhibitorsen_US
dc.subjectN-methyl D-aspartate receptor antagonisten_US
dc.subjectAmyloid betaen_US
dc.subjectNeurofibrillary tanglesen_US
dc.titleTherapeutic potentials of herbal drugs for Alzheimer’s disease—An overviewen_US
Appears in Collections:IJEB Vol.55(02) [February 2017]

Files in This Item:
File Description SizeFormat 
IJEB 55(2) 63-73.pdf285.35 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.